A Clinical Study Of Charakokta Tejovatyadi Ghrut In The Management Of Tamaka Shwasa W.S.R. TO BRONCHIAL ASTHMA
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- improvement in subjective parameters like Ativativraveg Shwasa Sannirudhyate Kasa Uddhavamsate kantha Ghurghurak Ucchritaksha Pratamyati Lalaten Svidyate Trut Visushkasyam
研究概览
简要总结
TITLE A CLINICAL STUDY OF CHARAKOKTA TEJOVATYADI GHRUT IN THE MANAGEMENT OF TAMAKA SHWASA W.S.R. TO BRONCHIAL ASTHMA
INTRODUCTION Shwasa word is used to denote respiration and exchange of air in the body The word Shwasa is used for both physiological and pathological conditions Tamaka Shwasa is a chronic respiratory disorder described in Ayurvedic classics closely correlated with Bronchial Asthma in modern medicine It is one of the five types of Shwasa Roga respiratory diseases Tamaka Shwasa is primarily caused by the vitiation of Vata and Kapha doshas leading to obstruction in the respiratory channels Pranavaha Srotas Resulting in difficulty in breathing wheezing and a sense of chest tightness It is typically characterised by recurrent attacks of breathlessness especially worsened at night and early morning
NEED OF RESEARCH Indian study on epidemiology of asthma respiratory symptoms and chronic bronchitis in adults estimated that national burden of asthma at 17.23 million of population with an overall prevalence of 2.05 percent There are many drugs in modern medicine which do have potent bronchodilators and antispasmodic effect but none of them has got a curative potential and they are also required to be given for a very long duration of time On the other hand prolonged use of these drugs is not good for overall health as they have many adverse effects with systemic manifestations The need of some safe and potential ideal anti-asthmatic drug is always felt by medical fraternity. So the present study has been planned to assess the anti-asthmatic effect of Tejovatyadi Ghrut LAKSHANA
1 Ativativraveg Shwasa 2 Sannirudhyate 3 Kasa 4 Uddhavamsate kantha 5 Ghurghurak 6 Ucchritaksha 7 Pratamyati 8 Lalaten Svidyate 9 Trut 10 Visushkasyam
MATERIAL AND METHOD STUDY DESIGN Type of study An Open Labelled Randomized Clinical Trial with Pre and Post Design No of groups Single group Sample size 30 pt Study duration 2yr Duration of trial 21 days Follow up period 3 months Patients fulfilling the criteria of diagnosis and criteria of inclusion for the present study shall be randomly selected from the OPD and IPD of Government Autonomous Ayurveda College Nipaniya Rewa M P
PROBABLE MODE OF ACTION
USHNA VIRYA KATU VIPAKA Helps liquefy and expel the obstructed Kapha Deepana pachana Enhance digestive fire reduce formation of Ama sssssssssswhich is a root cause of chronic inflammation regulate the Pranavayu USHNA TIKSHNA LAGHU Helps in clearing the blocked channels Srotoshodhana Kaphavata shamak Prevents recurrent Kapha accumulation PIPPALI HARITAKI JIVANTI Rasayana effect Improves lung tissue strength Improve oja Enhance immunity GOGHRUT Yogvahi Enhance digestion and absorption Balya strengthens lungs
DRUG REVIEW TEJOVATYADI GHRITAM Tejovatyadi Ghrut Mode of administration Oral medication Form Ghrut Dose 12 gm Time of administration Twice a day (Morning & evening) Abhakt kala Duration 21 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having age in between 16 to 70 years of any gender.
- •Chronicity less than 1 year Patients having classical signs and symptoms of Tamaka Shwasa.
- •No recent respiratory infections or exacerbations.
- •Patients willing for the trial and ready to give informed consent.
排除标准
- •Patients of age less than 16 and greater than 70 years.
- •Patients not willing for the trial or not ready to give informed consent.
- •Patients who are using Bronchodilator Inhaler.
- •Uncontrolled hypertension & diabetes, cardiovascular disease, or renal/hepatic impairment, and history of active tuberculosis or pulmonary malignancy.
- •Diagnosis of COPD, Bronchiectasis, Interstitial Lung Disease, Vocal Cord Dysfunction, or Cystic Fibrosis.
- •Pregnant and lactating women.
结局指标
主要结局
improvement in subjective parameters like Ativativraveg Shwasa Sannirudhyate Kasa Uddhavamsate kantha Ghurghurak Ucchritaksha Pratamyati Lalaten Svidyate Trut Visushkasyam
时间窗: on 0 days to 21 days
次要结局
- improvement in subjective parameters like Ativativraveg Shwasa Sannirudhyate Kasa Uddhavamsate kantha Ghurghurak Ucchritaksha Pratamyati Lalaten Svidyate Trut Visushkasyam
研究者
Dr VARSHA TIWARI
Govt.Ayurveda College Nipaniya Rewa M.P